EFFICACY AND SAFETY OF TOFACITINIB AFTER FAILURE OF ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A US-BASED PROPENSITY MATCHED COHORT STUDY

被引：0
|
作者：
Kochhar, Gursimran S.
Desai, Aakash
Dulai, Parambir S.
Cross, Raymond K.
Farraye, Francis A.
Regueiro, Miguel D.
El-Hachem, Sandra
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1711
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF INFLIXIMAB AFTER FAILURE OF SUBCUTANEOUS ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY
    Streichenberger, Aurelie
    Pariente, Benjamin
    Bozon, Anne
    Arab, Nadia
    Amiot, Aurelien
    Vuitton, Lucine
    Tilmant, Marion
    Nachury, Maria
    Altwegg, Romain
    Delasalle, Thibault
    Gagniere, Charlotte
    Boivineau, Gregoire
    Fumery, Mathurin
    Wils, Pauline
    de Chambrun, Guillaume Pineton
    Hebuterne, Xavier
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S834 - S834
  • [2] Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study
    Hupe, Marianne
    Riviere, Pauline
    Nancey, Stephane
    Roblin, Xavier
    Altwegg, Romain
    Filippi, Jerome
    Fumery, Mathurin
    Bouguen, Guillaume
    Peyrin-Biroulet, Laurent
    Bourreille, Arnaud
    Caillo, Ludovic
    Simon, Mireille
    Goutorbe, Felix
    Laharie, David
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 852 - 860
  • [3] Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study
    Streichenberger, A.
    Pariente, B.
    Bozon, A.
    Arab, N.
    Amiot, A.
    Vuitton, L.
    Tilmant, M.
    Nachury, M.
    Altwegg, R.
    Delasalle, T.
    Gagniere, C.
    Gregoire, B.
    Fumery, M.
    Wils, P.
    de Chambrun, G. Pineton
    Hebuterne, X.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S291 - S291
  • [4] MUCOSAL HEALING WITH A SECOND ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS AFTER THE FAILURE OF THE PREVIOUS ANTI-TNF TREATMENT
    Papa, A.
    Pugliese, D.
    De Vitis, I.
    D'Aversa, F.
    Landi, R.
    Felice, C.
    Guidi, L.
    Armuzzi, A.
    Rapaccini, G. L.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E203 - E203
  • [5] Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent
    Buisson, A.
    Nachury, M.
    Fumery, M.
    Guilmoteau, T.
    Leclerc, E.
    Altwegg, R.
    Serrero, M.
    Mathieu, N.
    Treton, X.
    Vuitton, L.
    Pereira, B.
    Amiot, A.
    Bouguen, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I120 - I120
  • [6] REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
    Buisson, Anthony
    Nachury, Maria
    Fumery, Mathurin
    Guilmoteau, Thomas
    Leclerc, Eloise
    Altwegg, Romain
    Serrero, Melanie
    Mathieu, Nicolas
    Treton, Xavier
    Vuitton, Lucine
    Pereira, Bruno
    Amiot, Aurelien
    Bouguen, Guillaume
    GASTROENTEROLOGY, 2022, 162 (07) : S604 - S604
  • [7] TREATMENT PERSISTENCE RATES WITH TOFACITINIB IN A REAL-WORLD COHORT OF ANTI-TNF REFRACTORY ULCERATIVE COLITIS PATIENTS
    Conley, Thomas
    Colclough, James
    Liu, Eleanor
    Razanskaite, Violeta
    Jakobek, William
    Limdi, Jimmy
    Flanagan, Paul
    Subramanian, Sreedhar
    GUT, 2021, 70 : A88 - A89
  • [8] Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID
    Uzzan, Mathieu
    Nachury, Maria
    Nuzzo, Alexandre
    Amiot, Aurelien
    Caron, Benedicte
    Benezech, Alban
    Buisson, Anthony
    Bouguen, Guillaume
    Le Berre, Catherine
    Reenaers, Catherine
    Le Cosquer, Guillaume
    Savoye, Guillaume
    Charkaoui, Maeva
    Vidon, Mathias
    Guillo, Lucas
    Fumery, Mathurin
    Peyrin-Biroulet, Laurent
    Kirchgesner, Julien
    Bouhnik, Yoram
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (03): : 424 - 430
  • [9] Does failure to respond to one anti-TNF agent in Ulcerative Colitis predict treatment failure with other anti-TNF agents?
    AlAlawi, F.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S254 - S254
  • [10] Does Failure to Respond to One Anti-TNF Agent in Ulcerative Colitis Predict Treatment Failure With Other Anti-TNF Agents
    AlAlawi, Fatema
    Keegan, Denise
    Byrne, Kathryn
    Mulcahy, Hugh
    Cullen, Garret
    Doherty, Glen A.
    GASTROENTEROLOGY, 2015, 148 (04) : S266 - S267
12345